Cargando…

Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2

Angiogenesis, the process of new blood vessel formation from pre-existing ones, plays a key role in various physiological and pathological conditions. Alteration of the angiogenic balance, consequent to the deranged production of angiogenic growth factors and/or natural angiogenic inhibitors, is res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Presta, Marco, Foglio, Eleonora, Churruca Schuind, Ander, Ronca, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187966/ https://www.ncbi.nlm.nih.gov/pubmed/30349543 http://dx.doi.org/10.3389/fimmu.2018.02327

Ejemplares similares

Endogenous Long Pentraxin 3 Exerts a Protective Role in a Murine Model of Pulmonary Fibrosis
por: Maccarinelli, Federica, et al.
Publicado: (2021)

Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
por: Rodrigues, Priscila Fabiana, et al.
Publicado: (2018)

Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide
por: Leali, Daria, et al.
Publicado: (2010)

Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
por: Ronca, Roberto, et al.
Publicado: (2021)

Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
por: Matarazzo, Sara, et al.
Publicado: (2019)

The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
por: Turati, Marta, et al.
Publicado: (2022)

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer
por: Ronca, Roberto, et al.
Publicado: (2017)

The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
por: Giacomini, Arianna, et al.
Publicado: (2023)

A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
por: Giacomini, Arianna, et al.
Publicado: (2015)

Pentraxin 3 in Cardiovascular Disease
por: Ristagno, Giuseppe, et al.
Publicado: (2019)

The Long Pentraxin PTX3 in Bone Homeostasis and Pathology
por: Parente, Raffaella, et al.
Publicado: (2019)

Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers
por: Pavanello, Sofia, et al.
Publicado: (2017)

Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells
por: Ronca, Roberto, et al.
Publicado: (2009)

Cancer-associated Fibroblasts Communicate with Breast Tumor Cells Through Extracellular Vesicles in Tumor Development
por: Castillo-Sanchez, Rocio, et al.
Publicado: (2022)

Structural insights into the biological functions of the long pentraxin PTX3
por: Massimino, Anna Margherita, et al.
Publicado: (2023)

The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair
por: Grčević, Danka, et al.
Publicado: (2018)

The Long Pentraxin PTX3 Controls Klebsiella Pneumoniae Severe Infection
por: Asgari, Fatemeh, et al.
Publicado: (2021)

Pentraxin 3: An Immuno-Regulator in the Lungs
por: Balhara, Jyoti, et al.
Publicado: (2013)

Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
por: Guerra, Jessica, et al.
Publicado: (2020)

Pentraxins in Complement Activation and Regulation
por: Ma, Ying Jie, et al.
Publicado: (2018)

Regulation of the Complement System by Pentraxins
por: Haapasalo, Karita, et al.
Publicado: (2019)

The Long Pentraxin PTX3 Is of Major Importance Among Acute Phase Proteins in Chickens
por: Burkhardt, Nina B., et al.
Publicado: (2019)

Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response
por: Albonici, Loredana, et al.
Publicado: (2022)

Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections
por: Parente, Raffaella, et al.
Publicado: (2021)

The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
por: Doni, Andrea, et al.
Publicado: (2019)

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease
por: Marschner, Julian A., et al.
Publicado: (2018)

Source of Circulating Pentraxin 3 in Septic Shock Patients
por: Albert Vega, Chloé, et al.
Publicado: (2019)

Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19
por: Lapadula, Giuseppe, et al.
Publicado: (2022)

The Protective Effect against Extracellular Histones Afforded by Long-Pentraxin PTX3 as a Regulator of NETs
por: Daigo, Kenji, et al.
Publicado: (2016)

The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis
por: Porte, Rémi, et al.
Publicado: (2019)

The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs
por: Pepys, Mark. B.
Publicado: (2018)

Pentraxins and Fc Receptor-Mediated Immune Responses
por: Lu, Jinghua, et al.
Publicado: (2018)

The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility
por: Camaioni, Antonella, et al.
Publicado: (2018)

Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3
por: Porte, Rémi, et al.
Publicado: (2023)

Factor H–Related Protein 5 Interacts with Pentraxin 3 and the Extracellular Matrix and Modulates Complement Activation
por: Csincsi, Ádám I., et al.
Publicado: (2015)

The “sweet” side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation
por: Inforzato, Antonio, et al.
Publicado: (2013)

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
por: Wang, Zeyu, et al.
Publicado: (2020)

Editorial: Interactions of Pentraxins and Complement in Infection, Inflammation, and Cancer
por: Ma, Ying Jie, et al.
Publicado: (2022)

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
por: Gatto, Mariele, et al.
Publicado: (2019)

Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
por: Brilland, Benoit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o12qh267krt1ukgg8vd70k44r6